Moreover, chronic administration burdens (daily pills or injections for years) reduce compliance, especially in neurodegenerative conditions where cognitive impairment or motor deficits exist
Semaglutide and UTI risk has been studied extensively, and the findings mirror tirzepatide data
Checkpoint immunotherapy meets an ADC boom in gynecologic cancer care Platinum-resistant ovarian cancer, or PROC, remains a critical issue, but two evolving therapeutic strategies are transforming the landscape
People with diabetes need particular care because growth hormone can influence insulin sensitivity
There are no recommendations for daily intake, as L-carnitine is synthesized by the body itself
One of the latest advancements combines GLP-1 agonists with probiotics